
Biomarker Testing in Advanced NSCLC: A Pulmonology Perspective
Gaetane C. Michaud, MD
Chief of Interventional Pulmonary Medicine,
NYU Langone Health,
New York, New York
Dr. Michaud discusses how to facilitate a comprehensive diagnostic and molecular profiling of NSCLC through different types of biopsy techniques and sample acquisition tactics, onsite cytology consultations, and strategic use of biopsies
CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC

Case Study
Patient Case: Biomarker Testing in Advanced NSCLC

Chung-Che (Jeff) Chang, MD, PhD
A Case-Based Pathology Perspective on Biomarker Testing in NSCLC

Gaetane C. Michaud, MD
A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC

Mark A. Socinski, MD
A Case-Based Oncology Perspective on Biomarker Testing in NSCLC
IN ADVANCED NSCLC

Chung-Chee (Jeff) Chang, MD, PhD
A Pathology Perspective on Biomarker Testing in NSCLC

Martin Dietrich, MD, PhD
A Community Oncology Perspective on Biomarker Testing in NSCLC

Gaetane C. Michaud, MD
A Pulmonology Perspective on Biomarker Testing in NSCLC

Mark A. Socinski, MD
An Oncology Perspective on Biomarker Testing in NSCLC